Cancer BiologyResearchPeer-reviewed
METTL3 inhibition-activated cGAS/STING axis enhances immunotherapy and PARP inhibitor sensitivity of lung carcinoma
Jiawang Zhou, Jiaxin He, Yunqing Lu…·Hongsheng Wang
This study shows that inhibiting METTL3 activates the cGAS/STING pathway, enhancing anti-tumor immunity and PARP inhibitor sensitivity in lung carcinoma.
1 citation